| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27514 [R. A. H., J. C. B.], and Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [R. A. H., C. A. A., J. C. B.]
MLH1 is an integral part of the mismatch repair complex, and the loss of this protein is associated with the acquisition of a mutator phenotype, microsatellite instability, and a predisposition to cancer. Deficiencies in the mismatch repair complex, including the loss of MLH1, result in elevated resistance to specific inducers of DNA damage, yet the mechanisms involved in this DNA-damage resistance are largely unknown. Abnormal cellular responses to DNA damage can lead to the selection of cells with a greater propensity for neoplastic transformation and might also reduce the effectiveness of certain chemotherapeutic drugs. It is therefore important to identify agents that provide selective pressure for growth of MLH1-deficient cells and to characterize further the pathways involved. In this study, we show that both human epithelial and mouse embryo fibroblast cell lines lacking the MLH1 protein are more resistant to two inducers of oxidative stress, hydrogen peroxide and tert-butyl hydroperoxide. Our analyses suggest that the observed differences in cellular viability are mediated primarily through apoptotic pathways and not through deficiencies in cell cycle checkpoint controls. Additional characterization of the signaling pathways for hydrogen peroxide-induced apoptosis in MLH1-proficient cells demonstrates the involvement of increased mitochondrial permeability, the release of cytochrome c, and caspase 3 activation. Together, our data indicate that cells lacking MLH1 may possess a selective growth advantage under oxidatively stressed conditions via the disregulation of apoptosis, possibly involving the mitochondria.
This article has been cited by other articles:
![]() |
Y. Xie, H. Yang, J. H. Miller, D. M. Shih, G. G. Hicks, J. Xie, and R. P. Shiu Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation Carcinogenesis, April 1, 2008; 29(4): 722 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hecht and G. L. Mutter Molecular and Pathologic Aspects of Endometrial Carcinogenesis J. Clin. Oncol., October 10, 2006; 24(29): 4783 - 4791. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Menendez, A. Inga, and M. A. Resnick The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes. Mol. Cell. Biol., March 1, 2006; 26(6): 2297 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Risinger, G. L. Maxwell, G. V.R. Chandramouli, O. Aprelikova, T. Litzi, A. Umar, A. Berchuck, and J. C. Barrett Gene Expression Profiling of Microsatellite Unstable and Microsatellite Stable Endometrial Cancers Indicates Distinct Pathways of Aberrant Signaling Cancer Res., June 15, 2005; 65(12): 5031 - 5037. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Young, K. J. Thulien, M. R. Campbell, V. A. Tron, and S. E. Andrew DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study Carcinogenesis, October 1, 2004; 25(10): 1821 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yanamadala and M. Ljungman Potential Role of MLH1 in the Induction of p53 and Apoptosis by Blocking Transcription on Damaged DNA Templates Mol. Cancer Res., August 1, 2003; 1(10): 747 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Screaton, S. Kiessling, O. J. Sansom, C. B. Millar, K. Maddison, A. Bird, A. R. Clarke, and S. M. Frisch Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis PNAS, April 29, 2003; 100(9): 5211 - 5216. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mayer, H. Stoop, G. L. Scheffer, R. Scheper, J. W. Oosterhuis, L. H. J. Looijenga, and C. Bokemeyer Molecular Determinants of Treatment Response in Human Germ Cell Tumors Clin. Cancer Res., February 1, 2003; 9(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mayer, A. J. M. Gillis, W. Dinjens, J. W. Oosterhuis, C. Bokemeyer, and L. H. J. Looijenga Microsatellite Instability of Germ Cell Tumors Is Associated with Resistance to Systemic Treatment Cancer Res., May 1, 2002; 62(10): 2758 - 2760. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Glaab, R. B. Hill, and T. R. Skopek Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells Carcinogenesis, October 1, 2001; 22(10): 1709 - 1713. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |